Restructuring and Other Costs (Tables)

3 Months Ended

Apr. 01, 2023

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Other Costs by Segment

Restructuring and other costs by segment are as follows:

	Three months ended
(In millions)	April 1, 2023
Life Sciences Solutions	$	60
Analytical Instruments	—
Specialty Diagnostics	8
Laboratory Products and Biopharma Services	43
Corporate	1
	$	112

Summary of Changes in the Company's Accrued Restructuring Balance

The following table summarizes the changes in the company’s accrued restructuring balance, which is included in other accrued expenses in the accompanying balance sheet. Other amounts reported as restructuring and other costs in the accompanying statements of income have been summarized in the notes to the table.

(In millions)	Total (a)
Balance at December 31, 2022	$	41
Net restructuring charges incurred in 2023 (b)	50
Payments	(36)
Balance at April 1, 2023	$	55

(a)The movements in the restructuring liability principally consist of severance and other costs associated with facility consolidations.

(b)Excludes $62 million of net charges, principally $38 million of charges for impairment of long-lived assets in the Life Sciences Solutions and Laboratory Products and Biopharma Services segments, and, to a lesser extent, $18 million of net charges for pre-acquisition litigation and other matters.